DENVER, Feb. 8, 2017 /PRNewswire/ -- DaVita Kidney Care,
a division of DaVita Inc. (NYSE: DVA) and a leading
provider of kidney care services, today announced that it ranked
first in outcomes for the fourth year in a row in a recently
released report issued by the Centers for Medicare & Medicaid
Services (CMS) end stage renal disease (ESRD) Quality Incentive
Program (QIP).
"These results are a byproduct of our team's passion and
dedication to our patients," said Javier
Rodriguez, president and CEO of DaVita Kidney Care.
The ESRD QIP reduces payments to ESRD centers that do not meet
or exceed CMS-endorsed performance standards. DaVita outperformed
the rest of the industry combined, with only 11 percent of centers
receiving penalties versus 23 percent for the rest of the
industry.
In addition, DaVita had the highest average total performance
score among large dialysis organizations, which are organizations
that have at least 200 dialysis centers in the U.S.
"Clinical quality is our first priority at DaVita, as patients
trust in us to work with their doctors to provide the very best
care," said Allen R. Nissenson, M.D., FACP, chief medical
officer of DaVita Kidney Care. "We will build on this
four-year record of clinical excellence as we design and execute
our quality programs in 2017."
QIP is part of Medicare's ESRD program aimed at improving the
quality of care provided to Medicare patients. It was designed and
passed into law in part to be the nation's first
pay-for-performance quality incentive program. CMS describes QIP as
a "first-of-its-kind program [that] provides the ESRD community
with the opportunity to enhance the overall quality of care that
ESRD patients receive as they battle this devastating disease."
DaVita announced in October 2016
that it also outperformed the rest of the industry for the third
straight year in the CMS Five-Star Quality Rating System, a
separate system that rates dialysis centers based on clinical
performance and patient outcomes.
The full ESRD QIP reports can be downloaded at CMS.gov.
About DaVita Kidney
Care
DaVita Kidney Care is a division of DaVita
Inc., a Fortune 500® company that, through its operating
divisions, provides a variety of health care services to patient
populations throughout the United States and abroad. A
leading provider of dialysis services in the United
States, DaVita Kidney Care treats patients with chronic
kidney failure and end stage renal disease. DaVita Kidney
Care strives to improve patients' quality of life by
innovating clinical care, and by offering integrated treatment
plans, personalized care teams and convenient health-management
services. As of September 30, 2016, DaVita Kidney
Care operated or provided administrative services at 2,318
outpatient dialysis centers located in the United
States serving approximately 186,000 patients. The company
also operated 139 outpatient dialysis centers located in 11
countries outside the United States. DaVita Kidney
Care supports numerous programs dedicated to creating
positive, sustainable change in communities around the world. The
company's leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit DaVita.com/About.
DaVita is a registered trademark of DaVita Inc.
Contact Information
Media:
Ashley Henson
(303) 876-6626
ashley.henson@davita.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/government-report-shows-davita-has-top-clinical-outcomes-300404087.html
SOURCE DaVita Kidney Care